Our digital network:

Where am I?

Home

Regulation

Feature

To be clear on OTC regulation

Author: Matt Cameron

Source: Risk magazine | 04 Feb 2010

Categories: Regulation

Topics: House Financial Services Committee, Central counterparty (CCP), Clearing, Derivatives, US Senate

A US humorist once quipped: “Ancient Rome declined because it had a Senate. Now what’s going to happen to us with both a House and a Senate?” The...

Updating your subscription status

Not registered?

Subscribe to Risk magazine

Pay today for immediate access to Risk.net's premium content. As a subscriber you will have access to breaking news and analysis on sophisticated finance and regulation, derivatives and risk management articles.

Subscribe now

Start a one month free trial* to Risk magazine

All the business intelligence you need to stay ahead of the competition. Register here for your FREE one month trial to premium content and Risk.net's daily news and analysis service.
*(not available to current subscribers or previous/current trialists who have had more than 4 trials)

Start your free trial now

Corporate Licenses

A Risk.net corporate license is the most effective option to ensure your company is able to access the entire online news and analysis service. Call our corporate license team now so we can give you immediate access to all of Risk.net by either taking a trial or subscribing. Call Pat Courtney on +44(0) 207 484 9929

You must be a paid subscriber to Risk magazine to read the editorial, features and articles online.

Already registered?

Login

Username (email)

Password

Need help logging in?

Remember my login on this computer

Updating your subscription status

Login
Subscribe
Free trial
Email alerts

Sign up in 2 minutes for FREE and immediate access to premium content.

Click on one of the following publications to get started:

Join your company's corporate subscription

Every week our editorial team deliver a range of email bulletins to ensure our readers know what is happening in their markets around the world.

Email alerts

Weekly poll

Will Esma meet the deadline for Emir?

Esma is required to write much of the technical standards for Emir by June 30 – but the regulation has only just been finalised, and the authority had just 75 full-time staff at the end of 2011 (www.risk.net/2142483). Will it meet the deadline? Should Esma be given more resources?

	The June 30 deadline is not achievable under any circumstances
	The June 30 deadline is achievable, but only if Esma is given more resources
	The June 30 deadline is achievable with current resources

Technology white papers

Related Jobs

View all jobs

Topics of interest

Related brands:

© Incisive Media Investments Limited 2012, Published by Incisive Financial Publishing Limited, Haymarket House, 28-29 Haymarket, London SW1Y 4RX, are companies registered in England and Wales with company registration numbers 04252091 & 04252093

About us:

Related websites:

Related events:

LinkedIn:

Twitter:

Categories:

Accreditations:

Digital Publisher of the Year 2010

To be clear on OTC regulation

Not registered?

Already registered?

Sign up for Risk.net email alerts